NCT02215499: A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics |
|
|
| Completed | 1 | 28 | Europe | Placebo, Sodium Oxybate, Xyrem®, JZP-386 | Concert Pharmaceuticals | Narcolepsy, Excessive Daytime Sleepiness | 11/14 | 11/14 | | |
